Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection
BACKGROUND: Loss of bronchoprotection routinely follows regular treatment with beta2-agonists. There are no data on the effects on bronchoprotection for thrice weekly use of a beta2-agonist.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2003-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2003/148740 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558957257818112 |
|---|---|
| author | Beth E Davis John K Reid Donald W Cockcroft |
| author_facet | Beth E Davis John K Reid Donald W Cockcroft |
| author_sort | Beth E Davis |
| collection | DOAJ |
| description | BACKGROUND: Loss of bronchoprotection routinely follows regular
treatment with beta2-agonists. There are no data on the effects
on bronchoprotection for thrice weekly use of a beta2-agonist. |
| format | Article |
| id | doaj-art-c57b2cda96e64c0a819f984a9d9e126e |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2003-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-c57b2cda96e64c0a819f984a9d9e126e2025-02-03T01:31:17ZengWileyCanadian Respiratory Journal1198-22412003-01-01101232610.1155/2003/148740Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to BronchoprotectionBeth E Davis0John K Reid1Donald W Cockcroft2Division of Respiratory Medicine, Department of Medicine, Royal University Hospital, Saskatoon, Saskatchewan, CanadaDivision of Respiratory Medicine, Department of Medicine, Royal University Hospital, Saskatoon, Saskatchewan, CanadaDivision of Respiratory Medicine, Department of Medicine, Royal University Hospital, Saskatoon, Saskatchewan, CanadaBACKGROUND: Loss of bronchoprotection routinely follows regular treatment with beta2-agonists. There are no data on the effects on bronchoprotection for thrice weekly use of a beta2-agonist.http://dx.doi.org/10.1155/2003/148740 |
| spellingShingle | Beth E Davis John K Reid Donald W Cockcroft Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection Canadian Respiratory Journal |
| title | Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection |
| title_full | Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection |
| title_fullStr | Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection |
| title_full_unstemmed | Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection |
| title_short | Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection |
| title_sort | formoterol thrice weekly does not result in the development of tolerance to bronchoprotection |
| url | http://dx.doi.org/10.1155/2003/148740 |
| work_keys_str_mv | AT bethedavis formoterolthriceweeklydoesnotresultinthedevelopmentoftolerancetobronchoprotection AT johnkreid formoterolthriceweeklydoesnotresultinthedevelopmentoftolerancetobronchoprotection AT donaldwcockcroft formoterolthriceweeklydoesnotresultinthedevelopmentoftolerancetobronchoprotection |